Ugint Co Ltd (195990) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ugint Co Ltd (195990) has a cash flow conversion efficiency ratio of -0.098x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-5.55 Billion ≈ $-3.76 Million USD) by net assets (₩56.88 Billion ≈ $38.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Ugint Co Ltd for the company's overall valuation and market capitalisation.
Ugint Co Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Ugint Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Ugint Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ugint Co Ltd ranked by their cash flow conversion efficiency. Explore how high is Ugint Co Ltd's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bytes Technology Ltd
LSE:BYIT
|
0.626x |
|
Impedimed Ltd
AU:IPD
|
-1.053x |
|
SILVER DOLLAR RES
F:4YW
|
-0.008x |
|
Nosa Med AB
ST:NOSA
|
-0.043x |
|
Pluri Inc.
NASDAQ:PLUR
|
0.347x |
|
Thunderful Group AB
ST:THUNDR
|
-0.023x |
|
Glen Burnie Bancorp
NASDAQ:GLBZ
|
0.020x |
|
Mcphersons Ltd
AU:MCP
|
0.083x |
Annual Cash Flow Conversion Efficiency for Ugint Co Ltd (2014–2025)
The table below shows the annual cash flow conversion efficiency of Ugint Co Ltd from 2014 to 2025. View 195990 stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩54.03 Billion ≈ $36.61 Million |
₩-6.69 Billion ≈ $-4.53 Million |
-0.124x | -132.38% |
| 2024-12-31 | ₩108.01 Billion ≈ $73.20 Million |
₩-5.75 Billion ≈ $-3.90 Million |
-0.053x | -33.99% |
| 2023-12-31 | ₩122.34 Billion ≈ $82.91 Million |
₩-4.86 Billion ≈ $-3.30 Million |
-0.040x | +55.28% |
| 2022-12-31 | ₩140.20 Billion ≈ $95.01 Million |
₩-12.46 Billion ≈ $-8.44 Million |
-0.089x | -450.68% |
| 2021-12-31 | ₩137.54 Billion ≈ $93.21 Million |
₩-2.22 Billion ≈ $-1.50 Million |
-0.016x | -181.33% |
| 2020-12-31 | ₩139.10 Billion ≈ $94.27 Million |
₩2.76 Billion ≈ $1.87 Million |
0.020x | -12.06% |
| 2019-12-31 | ₩118.43 Billion ≈ $80.26 Million |
₩2.67 Billion ≈ $1.81 Million |
0.023x | -2.18% |
| 2018-12-31 | ₩106.88 Billion ≈ $72.43 Million |
₩2.47 Billion ≈ $1.67 Million |
0.023x | +106.58% |
| 2017-12-31 | ₩97.64 Billion ≈ $66.17 Million |
₩-34.22 Billion ≈ $-23.19 Million |
-0.350x | -266.08% |
| 2016-12-31 | ₩109.66 Billion ≈ $74.31 Million |
₩-10.50 Billion ≈ $-7.11 Million |
-0.096x | -2962.45% |
| 2015-12-31 | ₩103.84 Billion ≈ $70.37 Million |
₩-324.61 Million ≈ $-219.98K |
-0.003x | -135.88% |
| 2014-12-31 | ₩66.79 Billion ≈ $45.26 Million |
₩581.94 Million ≈ $394.37K |
0.009x | -- |
About Ugint Co Ltd
RootK Co., Ltd. manufactures and sells machine tools and biotechnology products in South Korea and internationally. It offers tapping centers, spindle machines, machining and turning centers, and machining centers with long table. Additionally, It also offers bispecific antibody therapeutics for ophthalmic and oncology indications, including anti-VEGF/ANG2, anti-HER2/CD3, anti-GPC3/CD3, and anti-… Read more